Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

FDA Pushes Back Prevnar Decision

By Drug Discovery Trends Editor | August 1, 2011

NEW YORK (AP) – Pfizer Inc. said that U.S. regulators will take another three months to consider approving its Prevnar 13 pneumococcal vaccine for use in adults.

Pfizer said the Food and Drug Administration now expects to make a decision by January 2012. The agency will use the time to consider additional data submitted by Pfizer that supports the use of the vaccine in adults age 50 and older.

Prevnar 13 is the world’s biggest-selling vaccine. It brought Pfizer $3.7 billion in worldwide revenue in 2010, and an expanded marketing approval would boost its sales. That would help make up for the loss of revenue from other products like the cholesterol drug Lipitor, which loses patent protection Nov. 30.

Prevnar 13 protects against 13 strains of pneumococcal disease, which can cause ear infections, meningitis and pneumonia. The FDA approved it in February 2010 for use in infants and young children. The vaccine was a key piece of Pfizer’s $68 billion acquisition of Wyeth in October 2009.

Date: July 29, 2011
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority
Portrait photo of Pfizer EVP and Medtronic board member Lidia Fonseca
Medtronic appoints Pfizer EVP as independent board director

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50